Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

Last updated: July 31, 2024
Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Overall Status: Active - Recruiting

Phase

1

Condition

Soft Tissue Infections

Treatment

Collagen hydrolyzed peptides

Clinical Study ID

NCT06138236
PFESWTCP
  • Ages 18-80
  • All Genders

Study Summary

Patients suffering from Plantar Fasciitis were randomized into three groups:

the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Plantar fascitiis Aged between 18 and 80 years old

Exclusion

Exclusion Criteria:

  • Previous surgery of the foot

  • Contraindications to ESWT

Study Design

Total Participants: 84
Treatment Group(s): 1
Primary Treatment: Collagen hydrolyzed peptides
Phase: 1
Study Start date:
July 01, 2023
Estimated Completion Date:
December 31, 2024

Study Description

Patients suffering from Plantar Fasciitis were randomized into three groups:

the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Aim of the study was to consider any difference in the outcome of the three groups of patients. The NRS and the AFAS score were considered for the outcome measurement.

Connect with a study center

  • Angela Notarnicola

    Bari, 70124
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.